related machine failures since neither doctors nor customers have all of the data necessary to make satisfactory judgments of solution top quality and legal tort therapies are sluggish, inefficient, and very pricey. The changes to the CGMP regulation would require manufacturers to extend [Web site 52644] their high quality methods to include severa